OTC Consumer Health Market Growth 2025 BURLINGAME, CA, UNITED STATES, March 11, 2025 /EINPresswire / --The Global OTC Consumer Health ...

A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache segment in India.On 11 November 2014, Sanofi India ...

These products are sold principally in the prescription market, but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas: Sanofi’s CEO ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...

Pertussis Treatment Market Pertussis Medications and Vaccinations Leading Therapeutic Approaches Driving Stance of Companies in the Market: ...

Over the past decade researchers have uncovered significant links between many of our most commonly used drugs - and patients taking them suffering depression.

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for ... 100 million deal by Sanofi earlier this ...

California allowed college athletes to earn money, profiting off their name, image and likeness. University records show ...

The U.S. over the counter (OTC) drugs market was valued at US$ 41.93 billion in 2024 and is projected to reach a market valuation of US$ 69.65 billion by 2033, growing at a CAGR of 5.8% during the ...

The FDA released results from its investigation of benzene in acne products containing benzoyl peroxide. In light of these ...

The following seven leading European stocks all offer significant scale, along with insulation from U.S. market volatility ...